In head and neck cancer, PLK-1 levels positively correlate with lymph node metastasis and poor prognosis, thus implicating PLK-1 as a prognostic marker [12,13,14]. This evidence concerns the gene PLK1 and metastatic malignant neoplasm in the lymph nodes.